Subscribe To
U.s. fda approves expanded use of biomarin's dwarfism therapy
The U.S. Food and Drug Administration (FDA) on Friday approved the expanded use of BioMarin pharmaceutical...
October 20, 2023, 4:15 pm
: lipella pharmaceuticals stock more than doubles in 3 days as fda approves ind for olp treatment
Shares of Lipella pharmaceuticals Inc. LIPO rocketed 52.2% higher in very active tracing Friday, after ...
October 20, 2023, 2:47 pm
Adial pharmaceuticals announces $4 million private placement priced at-the-market under nasdaq rules
CHARLOTTESVILLE, Va., Oct. 20, 2023 (GLOBE NEWSWIRE) — Adial pharmaceuticals, Inc. (NASDAQ:ADIL) (“...
October 20, 2023, 12:00 pm
Biocryst to host r&d day on november 3
RESEARCH TRIANGLE PARK, N.C., Oct. 20, 2023 (GLOBE NEWSWIRE) — BioCryst pharmaceuticals, Inc. (Nasdaq...
October 20, 2023, 11:00 am
Lipella pharmaceuticals stock more than doubles in 3 days as fda approves ind for olp treatment
Shares of Lipella pharmaceuticals Inc. LIPO, +51.55% rocketed 52.2% higher in very active tracing Frida...
October 20, 2023, 10:47 am
What's in store for west pharmaceutical (wst) in q3 earnings?
West pharmaceutical's (WST) third-quarter 2023 results are likely to reflect strength in the Proprietar...
October 20, 2023, 9:01 am
Why is xortx therapeutics (xrtx) stock up 110% today?
Xortx Therapeutics (NASDAQ: XRTX ) stock is climbing higher on Friday despite a lack of news from the pharmac...
October 20, 2023, 8:42 am
Arcutis announces pricing of $100 million public offering
WESTLAKE VILLAGE, Calif., Oct. 19, 2023 (GLOBE NEWSWIRE) — Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT) (“Arcutis”), an early commercial-stage b...
October 20, 2023, 3:45 am
Biomarin: growth drivers remain intact
During Q2 2023, BioMarin pharmaceutical's revenues for the quarter has reached $595.3 million, a 12% Yo...
October 19, 2023, 11:04 pm
Terns pharmaceuticals to participate in upcoming investor conferences
FOSTER CITY, Calif., Oct. 19, 2023 (GLOBE NEWSWIRE) — Terns pharmaceuticals, Inc. (“Terns” or the...
October 19, 2023, 8:05 pm
Shareholder alert: pomerantz law firm investigates claims on behalf of investors of alnylam pharmaceuticals, inc. – alny
NEW YORK, Oct. 19, 2023 (GLOBE NEWSWIRE) — Pomerantz LLP is investigating claims on behalf of investors of Alnylam ...
October 19, 2023, 7:33 pm
Shareholder alert: levi & korsinsky, llp notifies investors of an investigation involving possible securities fraud violations by officers of alnylam pharmaceuticals, inc.(alny)
NEW YORK, Oct. 19, 2023 (GLOBE NEWSWIRE) — Levi & Korsinsky notifies investors that it has commenced an investigation of Alnylam ...
October 19, 2023, 5:13 pm
Webinar invitation: transform pharma with ai driven insights
BLOOMINGTON, Ind., Oct. 19, 2023 (GLOBE NEWSWIRE) — Medical teams of life sciences and pharmaceutical...
October 19, 2023, 4:46 pm
Gild or vrtx: which is the better value stock right now?
Investors interested in Medical - Biomedical and Genetics stocks are likely familiar with Gilead Sciences (GILD) and Vertex ...
October 19, 2023, 12:47 pm
Adial pharmaceuticals to present at the fall foliage microcap rodeo conference on october 25th
CHARLOTTESVILLE, VA / ACCESSWIRE / October 19, 2023 / Adial pharmaceuticals, Inc. (NASDAQ:ADIL) ("Adial...
October 19, 2023, 12:00 pm
Pfizer wins unconditional eu antitrust okay for $43 bln seagen buy
U.S. pharmaceutical company Pfizer gained unconditional EU antitrust approval on Thursday for its propo...
October 19, 2023, 10:54 am
Is invesco pharmaceuticals etf (pjp) a strong etf right now?
A smart beta exchange traded fund, the Invesco pharmaceuticals ETF (PJP) debuted on 06/23/2005, and off...
October 19, 2023, 7:31 am
In need of a turnaround: will walgreens' new ceo cut or spare its high-yield dividend?
A healthcare and pharmaceutical benefits manager veteran is coming in to lead the turnaround....
October 19, 2023, 6:02 am
Verona pharma to report third quarter 2023 financial results and provide corporate update
LONDON and RALEIGH, N.C., Oct. 19, 2023 (GLOBE NEWSWIRE) -- Verona Pharma plc (Nasdaq: VRNA) (“Verona Pharma” or the “Company”), a clinical-st...
October 19, 2023, 2:00 am
Ultragenyx announces pricing of public offering of common stock and pre-funded warrants
NOVATO, Calif., Oct. 18, 2023 (GLOBE NEWSWIRE) — Ultragenyx pharmaceutical Inc. (NASDAQ: RARE), a bio...
October 19, 2023, 1:16 am